The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis
Abstract
BACKGROUND: Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), often termed Hashimoto encephalopathy, is a poorly understood and often misdiagnosed entity. OBJECTIVE: To characterize the clinical, laboratory, and radiologic findings in patients with SREAT to potentially improve recognition of this treatable entity. DESIGN: Retrospective analysis of clinical features and diagnostic test data. SETTING: Two affiliated tertiary care referral institutions. PATIENTS: Twenty consecutive (6 male) patients diagnosed as having SREAT from 1995 to 2003. MAIN OUTCOME MEASURES: Clinical features and ancillary test findings associated with SREAT. RESULTS: The median age at disease onset was 56 years (range, 27-84 years). The most frequent clinical features were tremor in 16 (80%), transient aphasia in 16 (80%), myoclonus in 13 (65%), gait ataxia in 13 (65%), seizures in 12 (60%), and sleep abnormalities in 11 (55%). All patients were assigned an alternative misdiagnosis at presentation, most commonly viral encephalitis (n = 5), Creutzfeldt-Jakob disease (n = 3), or a degenerative dementia (n = 4). The most frequent laboratory abnormalities were increased liver enzyme levels in 11, increased serum sensitive thyroid-stimulating hormone levels in 11, and increased erythrocyte sedimentation rate in 5. In only 5 patients (25%) did cerebrospinal fluid abnormalities suggest an inflammatory process. Magnetic resonance imaging abnormalities believed to be related to the encephalopathy were present in 5 patients (26%). CONCLUSIONS: The clinical, laboratory, and radiologic findings associated with SREAT are more varied than previously reported. Misdiagnosis at presentation is common. This treatable syndrome should be considered even if the serum sensitive thyroid-stimulating hormone level and erythrocyte sedimentation rate are normal, the cerebrospinal fluid profile does not suggest an inflammatory process, and neuroimaging results are normal. Until the pathophysiologic mechanism of this and other autoimmune encephalopathies is better characterized, we believe that descriptive terms that reflect an association rather than causation are most appropriate for this syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Hashimoto Encephalopathy: Syndrome or Myth?
Chong, J. Y., Rowland, L. P., & Utiger, R. D. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.164 · Cited by 563
HASHIMOTO'S DISEASE AND ENCEPHALOPATHY
BRAIN, L. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92876-5 · Cited by 526
Ellis, S. G., & Verity, M. A. (1979) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(79)80009-8 · Cited by 439
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Faber, R., & Neary, D. (1999) · Neurology · doi:10.1212/wnl.53.5.1158-b · Cited by 363
Encephalopathy associated with Hashimoto thyroiditis: Diagnosis and treatment
Kothbauer-Margreiter, I., Sturzenegger, M., Komor, J., Baumgartner, R., & Hess, C. W. (1996) · Journal of Neurology · doi:10.1007/bf00900946 · Cited by 345
Shaw, P. J., Walls, T. J., Newman, P. K., Cleland, P. G., & Cartlidge, N. E. F. (1991) · Neurology · doi:10.1212/wnl.41.2_part_1.228 · Cited by 314
Lawn, N. D., Westmoreland, B. F., Kiely, M. J., Lennon, V. A., & Vernino, S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.11.1363 · Cited by 266
Self-citationHashimoto's encephalopathy: epidemiologic data and pathogenetic considerations
Ferracci, F., Bertiato, G., & Moretto, G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.09.007 · Cited by 258
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Geschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L. (2008) · Annals of Neurology · doi:10.1002/ana.21430 · Cited by 323
Hashimoto???s Encephalopathy: Epidemiology, Pathogenesis and Management
Mocellin, R., Walterfang, M., & Velakoulis, D. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00002 · Cited by 273
Geschwind, M. D., Haman, A., & Miller, B. L. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.001 · Cited by 143
Metadata
- Authors
- Castillo, P., Woodruff, B., Caselli, R., Vernino, S., Lucchinetti, C., Swanson, J., Noseworthy, J., Aksamit, A., Carter, J., Sirven, J., Hunder, G., Fatourechi, V., Mokri, B., Drubach, D., Pittock, S., Lennon, V., & Boeve, B.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2006-02-01
- Volume
- 63
- Issue
- 2
- Pages
- 197
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2012811274
- Cited by
- 528
- References
- 21
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis. https://app.cochat.ai/papers/10.1001/archneur.63.2.197
- The paper
- Castillo, P., Woodruff, B., Caselli, R., Vernino, S., Lucchinetti, C., Swanson, J., Noseworthy, J., Aksamit, A., Carter, J., Sirven, J., Hunder, G., Fatourechi, V., Mokri, B., Drubach, D., Pittock, S., Lennon, V., & Boeve, B. (2006). Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis. Archives of Neurology. https://doi.org/10.1001/archneur.63.2.197
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.